Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
Ulrike Blume-PeytaviZahida IssiakhemStephanie GautierJan KottnerWalter Wigger-AlbertiTobias FischerRolf HoffmannFrançoise TonnerAthmane BouroubiJean-Jacques VoisardPublished in: Journal of cosmetic dermatology (2018)
DC0120 was as safe and effective as a similar marketed minoxidil product for stimulating hair growth in men with AGA.